$URGN

$33.91 -$0.13 (0.38%) Close

$URGN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$URGN Management Team

Mr. Christopher Degnan

Chief Financial Officer

Principal Accounting Officer

Principal Financial Officer

Age 45

Compensation $1.054M USD

Sex Male

Mr. Jason Smith

Chief Compliance Officer

General Counsel

Corporate Secretary

Age 53

Compensation $1.275M USD

Sex Male

Dr. Mark Schoenberg

Chief Medical Officer

Age 67

Compensation $1.361M USD

Sex Male

Dr. Arie Belldegrun

Independent Chairman of the Board

Age 75

Compensation $331.9K USD

Sex Male

Ms. Elizabeth Barrett

President

Chief Executive Officer

Director

Age 62

Compensation $4.150M USD

Sex Female

Mr. Vincent Perrone

Investor Relations

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Christopher Degnan Chief Financial Officer Principal Accounting Officer Principal Financial Officer	45	$1.054M USD	Male
Mr. Jason Smith Chief Compliance Officer General Counsel Corporate Secretary	53	$1.275M USD	Male
Dr. Mark Schoenberg Chief Medical Officer	67	$1.361M USD	Male
Dr. Arie Belldegrun Independent Chairman of the Board	75	$331.9K USD	Male
Ms. Elizabeth Barrett President Chief Executive Officer Director	62	$4.150M USD	Female
Mr. Vincent Perrone Investor Relations	-	-	Male

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

7.4 years

from year joined

CEO also chairs the board

Arie Belldegrun

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Arie Belldegrun Board chair	76	2012 14 years	Independent	None stated	None stated	$537,486
Elizabeth Barrett CEO	63	2019 7 years	Not independent	None stated	Allogene Therapeutics, Inc.	Paid as CEO
Cynthia M. Butitta	71	2017 9 years	Independent	None stated	Autolus, Ltd.	$389,743
Stuart Holden	83	2015 11 years	Independent	None stated	Clarus Therapeutics, Inc.	$382,243
James A. Robinson, Jr.	56	2023 3 years	Independent	None stated	Eledon Pharmaceuticals, Inc.	$383,221
Leana S. Wen	43	2022 4 years	Independent	None stated	Glaukos Corporation	Not stated
Daniel G. Wildman	69	2022 4 years	Independent	None stated	Nyxoah S.A.	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$URGN Management Team

Mr. Christopher Degnan

Mr. Jason Smith

Dr. Mark Schoenberg

Dr. Arie Belldegrun

Ms. Elizabeth Barrett

Mr. Vincent Perrone

Board of Directors

Related-party transactions

No related-party transactions disclosed